Welcome AM
近期投资事件
更多2022-05-25
RNA干扰（RNAi）技术疗法开发商
医药研发/制造
化学&生物药
Company K Partners;
Company K Partners;
Welcome AM;
Welcome AM;
IMM Investment;
Focus Asset Management;
Solidus Investment;
KB Investment;
Shinhan Capital
相关合作机构
最新投融资资讯
更多-
凯乘资本2026-09-08
-
融中财经2026-09-08
-
道远资本2026-09-08
-
17Talk易企说2026-09-08
-
药盟科技2026-09-08
-
合成药物2026-09-08
-
同写意2026-09-08
-
中睿创械2026-09-08
-
干细胞与外泌体2026-09-08
-
干细胞与外泌体2026-09-08